CTOs on the Move

Orbus Therapeutics

www.orbustherapeutics.com

 
Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

Orbus Therapeutics raised $18M on 08/21/2015

Similar Companies

Rep Fitness

REP Fitness is a home and commercial equipment supplier that specializes in strength and conditioning equipment. No matter what space youre working out in, REP has you covered.

Five Rivers Medical Center

Five Rivers Medical Center is a Pocahontas, AR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Metropolitan Health Networks

Metropolitan Health Networks, Inc. is a West Palm Beach, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Nutracea

Nutracea, Inc. is a Paradise Valley, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Med ISP

Med ISP is a Memphis, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.